COLORECTAL CANCER
SCREENING
RECOMMENDATIONS
Tracy S. d’Entremont, MD
Clinical Assistant Professor
Hematology-Oncology Division
Hospital of the University of Pennsylvania
COLORECTAL CANCER
 CRC is the second leading cause of cancer death in the US
 An estimated 134,000 new cases will be diagnosed in 2016.
 Anticipated 49,000 deaths annually from this disease.
 The goal of any screening program
 Prevention
 Early detection
 Increased survival
JAMA June 21, 2016.
BENEFITS OF SCREENING
Gastroenterology November 2012 143 (5): 1227-1236
TYPES OF TESTS
 Tests that mainly find Cancer
 High- Sensitivity fecal occult blood test (FOBT)
 Fecal Immunochemical test (FIT)
 Stool DNA Test
 Tests that find Polyps and Cancer
 Flexible Sigmoidoscopy
 CT Colonography (virtual colonoscopy)
 Colonoscopy
DEFINE YOUR RISK
 Average Risk
 Age 50-75 years
 High Risk
 Personal History of Colorectal Cancer or Adenomatous Polyps
 Personal History of Inflammatory Bowel Disease
 Family History of Hereditary Colon Cancer Syndrome
 Strong Family History of Colorectal Cancer or polyps
AVERAGE RISK PATIENTS
 Colonoscopy every 10 years
 Flex Sigmoidoscopy every 5 years
 Plus stool test annually
 CT colonography every 5 years
 Plus stool test annually
USPTF, ACS, CDC
HIGH RISK PATIENTS
 First Colonoscopy
 At age 40, or 10 years before the youngest case
of cancer in the family
 At age 10-12, for patients in FAP families
 At age 20, for Lynch syndrome families
 8 years after the onset of colitis for inflammatory
bowel patients
POLYPS
Hyperplastic
Adenomatous
If more than 3
any larger than a cm
or any dysplasia
close interval colonoscopy is recommended
Sessile
Unless whole polyp was removed,
follow up in 2-6 months
DETECTION
VS.
PREVENTION
MELANOMA
The American Cancer Society estimates there will be 76,380
cases of invasive melanoma diagnosed in 2016
And 10,100 deaths from the disease
Incidence since 1975 has been increasing annually
3.2% for men
2.4 % for women
Without any end in site
American Cancer Society
PREVENTION
Avoidance of UV Exposure
Sunscreen
Limiting sun exposure during peak hours
Sunglasses
Wide brimmed hats
Long sleeves
No tanning beds
Self Skin Examination
Assymetry
Border Irregularity
Color
Diameter
Evolving
Colon cancer screening recommendations

Colon cancer screening recommendations

  • 1.
    COLORECTAL CANCER SCREENING RECOMMENDATIONS Tracy S.d’Entremont, MD Clinical Assistant Professor Hematology-Oncology Division Hospital of the University of Pennsylvania
  • 2.
    COLORECTAL CANCER  CRCis the second leading cause of cancer death in the US  An estimated 134,000 new cases will be diagnosed in 2016.  Anticipated 49,000 deaths annually from this disease.  The goal of any screening program  Prevention  Early detection  Increased survival JAMA June 21, 2016.
  • 3.
    BENEFITS OF SCREENING GastroenterologyNovember 2012 143 (5): 1227-1236
  • 4.
    TYPES OF TESTS Tests that mainly find Cancer  High- Sensitivity fecal occult blood test (FOBT)  Fecal Immunochemical test (FIT)  Stool DNA Test  Tests that find Polyps and Cancer  Flexible Sigmoidoscopy  CT Colonography (virtual colonoscopy)  Colonoscopy
  • 5.
    DEFINE YOUR RISK Average Risk  Age 50-75 years  High Risk  Personal History of Colorectal Cancer or Adenomatous Polyps  Personal History of Inflammatory Bowel Disease  Family History of Hereditary Colon Cancer Syndrome  Strong Family History of Colorectal Cancer or polyps
  • 6.
    AVERAGE RISK PATIENTS Colonoscopy every 10 years  Flex Sigmoidoscopy every 5 years  Plus stool test annually  CT colonography every 5 years  Plus stool test annually USPTF, ACS, CDC
  • 7.
    HIGH RISK PATIENTS First Colonoscopy  At age 40, or 10 years before the youngest case of cancer in the family  At age 10-12, for patients in FAP families  At age 20, for Lynch syndrome families  8 years after the onset of colitis for inflammatory bowel patients
  • 8.
    POLYPS Hyperplastic Adenomatous If more than3 any larger than a cm or any dysplasia close interval colonoscopy is recommended Sessile Unless whole polyp was removed, follow up in 2-6 months
  • 10.
  • 11.
  • 12.
    The American CancerSociety estimates there will be 76,380 cases of invasive melanoma diagnosed in 2016 And 10,100 deaths from the disease Incidence since 1975 has been increasing annually 3.2% for men 2.4 % for women Without any end in site American Cancer Society
  • 13.
    PREVENTION Avoidance of UVExposure Sunscreen Limiting sun exposure during peak hours Sunglasses Wide brimmed hats Long sleeves No tanning beds
  • 14.
  • 15.

Editor's Notes

  • #5 FIT- hemoglobin in the stool 73.8% sensitive for detecting Ca; 23% sensitive for detecting Pre-Ca lesions newer more sens than FOBT; but RCT used FOBT to demonstrate dec mortality Stool DNA (KRAS, aberrant NDRG4, BMP3, b-actin, hemoglobin) 92.3% sens for Ca; 42 % sens for Pre-Ca lesions